key: cord-0932767-2cot9qwb
authors: Simpson, Joelle N.; Goyal, Monika K.; Cohen, Joanna S.; Badolato, Gia M.; McGuire, Mark; Ralph, Abigail; Boyle, Meleah D.; Hamburger, Ellen K.; Gorman, Kathleen C.; Cora-Bramble, Denice; Delaney, Meghan
title: Results of Testing Children for SARS-CoV-2 through a Community-based Testing Site
date: 2020-12-22
journal: J Pediatr
DOI: 10.1016/j.jpeds.2020.12.030
sha: e595b7e092f57f097781826cde2ec1814a041983
doc_id: 932767
cord_uid: 2cot9qwb

OBJECTIVE: To describe the demographics, clinical features and test results of children referred from their primary provider for SARS-CoV-2 in the community setting. STUDY DESIGN: Retrospective cross-sectional study of children ≤22 years of age who were tested for SARS-CoV-2 at a community-based specimen collection site in Washington, DC affiliated with a large children’s hospital between March 21 and May 16, 2020. RESULTS: Of the 1445 patients tested at the specimen collection site for SARS-CoV-2 virus, 408 (28.2%) had a positive PCR test. The daily positivity rate increased over the study period, from 5.4% during the first week to a peak of 47.4%. (P-trend <0.001). Patients with fever (aOR: 1.7; 95% CI 1.3, 2.3) or cough (aOR 1.4; 95% CI 1.1, 1.9) and those with known contact with someone with confirmed SARS-CoV-2 infection (aOR: 1.6; 95% CI 1.0, 2.4.) were more likely have a positive test, but these features were not-highly discriminating. CONCLUSIONS: In this cohort of mildly symptomatic or well children and adolescents referred to a community drive-through/walk-up SARS-CoV-2 testing site because of risk of exposure or clinical illness, one in four patients had a positive test. Children and young adults represent a considerable burden of SARS-CoV-2 infection. Assessment of their role in transmission is essential to implementing appropriate control measures.

Objective: To describe the demographics, clinical features and test results of children referred from their primary provider for SARS-CoV-2 in the community setting.

Study design: Retrospective cross-sectional study of children ≤22 years of age who were tested for SARS-CoV-2 at a community-based specimen collection site in Washington, DC affiliated with a large children's hospital between March 21 and May 16, 2020.

: Of the 1445 patients tested at the specimen collection site for SARS-CoV-2 virus, 408 (28.2%) had a positive PCR test. The daily positivity rate increased over the study period, from 5.4% during the first week to a peak of 47.4%. (P-trend <0.001). Patients with fever (aOR: 1.7; 95% CI 1.3, 2.3) or cough (aOR 1.4; 95% CI 1.1, 1.9) and those with known contact with someone with confirmed SARS-CoV-2 infection (aOR: 1.6; 95% CI 1.0, 2.4.) were more likely have a positive test, but these features were not-highly discriminating.

In this cohort of mildly symptomatic or well children and adolescents referred to a community drive-through/walk-up SARS-CoV-2 testing site because of risk of exposure or clinical illness, one in four patients had a positive test. Children and young adults represent a considerable burden of SARS-CoV-2 infection. Assessment of their role in transmission is essential to implementing appropriate control measures.

J o u r n a l P r e -p r o o f is comprised of youth <18 years old. Experience from China and Europe suggests children of all ages are susceptible to SARS-CoV-2, but the disease tends to be clinically milder compared with adults, with as many as 90% infected children being asymptomatic or having only mild or moderate symptoms. (2) (3) (4) Recent US data confirm this, but also include findings of a subset of patients with serious illness resulting in hospitalization, documenting that serious illness does occur in the pediatric population, possibly at higher rates than previously reported. (5, 6) A common challenge during the COVID-19 pandemic has been inadequate diagnostic testing capacity, limited personal protective equipment (PPE) and the need for social distancing in health care settings.(7) Drive-through/walk-up specimen collection sites for SARS-CoV-2 offer a community-based solution to these challenges. Regional variation in testing availability limits the ability to describe the referral patterns and clinical presentation of pediatric patients in the community setting. However, as the US reopens schools and childcare centers, information about the community spread of SARS-CoV-2 among children has attracted great attention to guide recovery planning.

Drive-through/walk-up testing sites outside of a traditional acute care setting have emerged around the world to meet the need for testing mildly ill or asymptomatic individuals. 

This was a cross-sectional study of children tested for SARS-CoV-2 at an exclusively pediatric drive-through/walk-up urban specimen collection site affiliated with a large, tertiary care children's hospital in Washington, DC from March 21 to May 16, 2020. Patients were referred by community pediatricians through an online registration and referral process. Selfreferral was not permitted. Referring clinicians included members of an affiliated clinically integrated network of more than 500 regional pediatricians. Pediatricians were advised to refer patients between the ages of 0-22 years if they reported mild symptoms or met the following criteria: patients who were at high risk for serious infection, patients who lived with high-risk household members, or who lived with household members whose work status would be impacted by the presence of infection. The site was located within one mile of the hospital at an outdoor parking lot of a local university and was operational 2-3 days per week. Patients were seen in single file and remained in their vehicle, or, if ambulatory, at least 6-feet apart from other patients. All specimens were collected via nasopharyngeal or oropharyngeal swab by trained healthcare workers and sent to an offsite commercial laboratory (Quest Diagnostics, Inc) for Emergency Use Authorization (EUA) approved real-time reverse transcription polymerase chain J o u r n a l P r e -p r o o f reaction testing (RT-PCR). Results were returned to the referring provider. The hospital's institutional review board approved this study.

Demographic and clinical data were extracted from the electronic referral forms and merged with laboratory results from the electronic medical record system. Data included the following: age, sex, race/ethnicity and home address. Consistent with other studies, race/ethnicity was categorized as non-Hispanic (NH) Black, NH-white, Hispanic, and other. (10) Age was organized into the following categories: <1, 1-4, 5-11, 12-17 and 18-22 years of age.

Home address was used to measure the distance from the testing site. The reason for referral was categorized as: high risk patient for exposure or infection, household member with high risk for exposure or infection, need to know status for work or contact tracing, and known exposure.

Reasons for referral were not mutually exclusive. Symptoms were classified into the following non-mutually exclusive categories: none, upper respiratory tract symptoms (e.g. sore throat or nasal congestion), cough, lower respiratory tract symptoms (eg, difficulty breathing), gastrointestinal symptoms (e.g. vomiting or diarrhea), neurologic symptoms (e.g headache) and

systemic symptoms (e.g. fever). Presence of symptoms was analyzed as a binary variable (yes/no).

We used standard descriptive statistics to summarize the study population. We performed bivariable logistic regression analyses to calculate unadjusted and adjusted odds ratios (OR) with 95% confidence intervals (CI) to identify demographic and clinical characteristics associated with SARS-CoV-2 infection. We also performed multivariable logistic regression that was a J o u r n a l P r e -p r o o f priori adjusted for age, race/ethnicity, sex and distance from testing site. We calculated SARS-CoV-2 positivity rates and assessed temporal trends in positivity rates over the study period using p-trend analyses. All analyses were conducted using SAS, version 9.4 (SAS Institute Inc., Cary, NC, USA).

Geospatial analysis was conducted using ArcGIS Pro. Home addresses were geocoded to create a point layer with all patients tested and patients tested positive. Patients were excluded from the geospatial analysis if they had invalid addresses (n=12). The point layers were spatially joined with a zip code polygon layer to develop a map with pie charts to view the spatial distribution of testing and positivity by zip code. 

The median age of all the patients tested was 8 (IQR: 3, 14) years and 34.7% of patients were Hispanic ethnicity, followed by non-Hispanic Black (28.3%) and non-Hispanic white (16.8%) ( Table I) .

Patients were referred to the testing site using telemedicine (44.3%), office visits (15.4%) and telephone calls (7.6%). The most common reasons were a high-risk family member (35%) or need to know for work (30%). (Figure 2 ) Of those tested, 83.7% (N=1210) had symptoms documented by the referring provider. The most common symptoms reported were lower respiratory complaints (41.6%) and fever (35%). (Table 2 ) The median distance from the patients' homes to the specimen collection site was 7.3 miles (IQR: 4.3, 12.9); the farthest distance traveled was 73.6 miles. (Figure 3 ; available at www.jpeds.com)

We found no notable sex or age differences among those with confirmed infection.

Compared with NH-white children and after adjustments for age, sex and distance of residence from specimen collection site, minority children had a higher likelihood of infection (Hispanic (Table 1) Patients who self-reported a known exposure to COVID-19 were more likely to test positive compared with those who did not report a known exposure (aOR: 1.6; 95% CI 1.0, 2.4.)

Other reasons for referral (need to know for work, high risk patient for exposure or infection, household member with high risk for exposure or infection) were not associated with positivity.

Patients with a cough (aOR 1.4; 95% CI: 1.1, 1.9) or fever (aOR: 1.7; 95% CI 1.3, 2.3) were more likely to have a positive test than patients without those symptoms. Neurologic, upper respiratory tract symptoms, lower respiratory tract symptoms and GI symptoms were not associated with testing positive in our population. (Table 2 )

This study describes the clinical and demographic characteristics of a large sample of children referred to a community-based SARS-CoV-2 drive-through/walk-up testing site in Washington, DC because of risk of exposure or infection or both. The overall positivity rate was nearly 30%; rates increased throughout the study period from approximately 5% to almost 50% at the peak on May 5, 2020. The daily positivity rates throughout the study period followed a trend similar to the overall population's SARS-CoV-2 rates for the Washington, DC and the surrounding regions, suggesting that children have a similar prevalence of viral infection compared with adults with risk factors for exposure, despite different rates of illness severity in children. (11) Patients with COVID-19 exposure and symptoms were more likely to have a positive test than patients without symptoms. This supports contact tracing for symptomatic cases and testing as an important tool in detecting and containing community spread. Although most patients were referred because they lived with a family member with high risk for exposure or infection, this was not associated with positive test results.

To alleviate the risk of unintentional viral transmission between patients and healthcare providers, physicians have rapidly adopted telemedicine during the pandemic. (12) In line with this recent transition, most referrals to the testing site were following telemedicine visits. The drive-through site allows pediatricians to avoid having to bring potentially infectious patients into their offices that may not be equipped with the PPE required to handle test collection safely.

This study had several limitations. This was a retrospective study reliant on the accuracy of the data collected at the time of physician referral and the electronic health record. 1.1, 1.8) 1.4 (1.1, 1.9 ) 

MMWR Morbidity and mortality weekly report

SARS-CoV-2 Infection in Children

Clinical characteristics of children with COVID-19: a rapid review and meta-analysis

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents: A Systematic Review

MMWR Morbidity and mortality weekly report

Severe COVID-19 in Children and Young Adults in the Washington, DC Metropolitan Region. The Journal of pediatrics

Responses of three urban

Institute of Medicine Subcommittee on Standardized Collection of Race/Ethnicity Data for Healthcare Quality I

A digital embrace to blunt the curve of COVID19

We thank the Children's National Hospital and George Washington University medical student volunteers that worked at the testing site. We also thank members of the Children's National Hospital COVID-19 Task Force under the leadership of Dr Kurt Newman that supported the planning and execution of the testing site. We are also grateful to Pat McGuire (President) and